(Q24647406)

1

0 references

Adam I Kaplin

2

0 references

Robert A Brodsky

3

0 references

Daniel B Drachman

4

0 references

Richard J Jones

5

0 references

Dzung L Pham

6

0 references

Nancy D Richert

7

0 references

Carlos A Pardo

8

0 references

David M Yousem

9

0 references

Edward Hammond

10

0 references

Megan Quigg

11

0 references

Carrilin Trecker

12

0 references

Justin C McArthur

13

0 references

Avindra Nath

14

0 references

Benjamin M Greenberg

15

0 references

Douglas A Kerr

Treatment of multiple sclerosis with cyclophosphamide: critical review of clinical and immunologic effects

17

0 references

language of work or name

English

0 references

publication date

August 2008

0 references

published in

Archives of Neurology

0 references

volume

65

0 references

issue

8

0 references

page(s)

1044-51

0 references

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2574697

High-dose cyclophosphamide for moderate to severe refractory multiple sclerosis

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2574697

Volumetric neuroimage analysis extensions for the MIPAV software package

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2574697

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2574697

High-dose therapy for autoimmune neurologic diseases

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2574697

Hematopoietic stem cell transplantation for multiple sclerosis. A retrospective multicenter study.

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2574697

Combination of cyclophosphamide and interferon-beta halts progression in patients with rapidly transitional multiple sclerosis

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2574697

Heterogeneity of multiple sclerosis pathogenesis: implications for diagnosis and therapy.

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2574697

Autologous stem cell transplantation in progressive multiple sclerosis--an interim analysis of efficacy

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2574697

High-dose immunosuppressive therapy with PBPC support in the treatment of poor risk multiple sclerosis.

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2574697

Development of a multiple sclerosis functional composite as a clinical trial outcome measure

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2574697

Recommendations from the National Multiple Sclerosis Society Clinical Outcomes Assessment Task Force

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2574697

Cyclophosphamide-induced immunological tolerance: an overview

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2574697

Chronic nontraumatic diseases of the spinal cord.

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2574697

Revised estimate of the prevalence of multiple sclerosis in the united states

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2574697

Autologous hematopoietic stem cell transplantation suppresses Gd-enhanced MRI activity in MS.

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2574697

Adaptive fuzzy segmentation of magnetic resonance images.

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2574697

High-dose cyclophosphamide without stem cell transplantation in systemic lupus erythematosus

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2574697

Treatment of refractory myasthenia: "rebooting" with high-dose cyclophosphamide

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2574697

Automated segmentation of multiple sclerosis lesions by model outlier detection.

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2574697

Peripheral blood stem cell transplantation in the treatment of progressive multiple sclerosis: first results of a pilot study

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2574697

Controlled pilot trial of monthly intravenous cyclophosphamide in multiple sclerosis

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2574697

Immunosuppression and plasmapheresis in chronic progressive multiple sclerosis. Design of a clinical trial

28 November 2018

1 reference

12 December 2020

Administration of monthly-pulse cyclophosphamide in multiple sclerosis patients. Effects of long-term treatment on immunologic parameters

1 reference

12 December 2020

Cyclophosphamide 'pulses' in chronic progressive multiple sclerosis. A preliminary clinical trial

1 reference

12 December 2020

Long-lasting effects of cyclophosphamide on lymphocytes in peripheral blood and spinal fluid

1 reference

12 December 2020

The Canadian cooperative trial of cyclophosphamide and plasma exchange in progressive multiple sclerosis. The Canadian Cooperative Multiple Sclerosis Study Group

1 reference

12 December 2020

Gadolinium dose optimisation in patients with multiple sclerosis: intra- and inter-individual comparisons

1 reference

12 December 2020

Autologous stem cell transplantation for progressive multiple sclerosis: Update of the European Group for Blood and Marrow Transplantation autoimmune diseases working party database

1 reference

12 December 2020

Interference with cyclophosphamide-induced skin allograft tolerance by cyclosporin A

1 reference

12 December 2020

Intermittent cyclophosphamide pulse therapy in progressive multiple sclerosis: final report of the Northeast Cooperative Multiple Sclerosis Treatment Group

1 reference

12 December 2020

Treatment of autoimmune disease by intense immunosuppressive conditioning and autologous hematopoietic stem cell transplantation

1 reference

12 December 2020

Immunoablative high-dose cyclophosphamide without stem-cell rescue for refractory, severe autoimmune disease

1 reference

12 December 2020

Treatment of the chronic progressive form of multiple sclerosis with a combination of cyclophosphamide and prednisone

1 reference

12 December 2020